Form D · Other Health Care
Fresenius Medical Care Secaucus, LLC
Waltham, MA · CIK 0001757815
Offering snapshot reported Nov 2, 2018 · SEC filing
- Reported sold
- $3.66M Offering amount: $3.66M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1.79M Reported outside-investor minimum
- First sale
- Oct 29, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2018 | Initial | $3,662,205 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324964
Source: Form D, filed Nov 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sam Hajal | Director |
| Debora Kearney | Director |
| David Levin | Director |
| Sharon Middleton | Director |
| Ryan M Valle | Director |
| Timothy Weaver | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Fresenius Medical Care North America 920 Winter Street
Waltham, MA, 02451
Waltham, MA, 02451